Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Spasticity
Trial Locations (8)

11410

Hospital General ISSSTE Tacuba /ID# 261460, Mexico City

Hospital General ISSSTE Tacuba /ID# 261932, Mexico City

44270

Cri Dif Jalisco /Id# 261459, Guadalajara

45653

Hospital General Regional 180 IMSS /ID# 261458, Guadalajara

48312

Clinica de Rehabilitacion Integral Yupi /Id# 261461, Puerto Vallarta

54010

Crit Estado de México /Id# 261934, Tlalnepantla

64790

Cree Dif Nuevo Leon /Id# 261454, Monterrey, Nuevo LEON

86100

Hospital Militar De Zona De Villahermosa /ID# 261451, Villahermosa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY